| Gene Symbol | CYC7 |
| Entrez Gene ID | 5071269 |
| Full Name | putative CYC2-like protein |
| Gene Type | protein-coding |
| Organism | Leishmania infantum JPCM5 |
- REAGENT SERVICES Hot!
-
PRODUCTS
-
Most Popular Reagents
-
Instruments
-
Antibodies
-
ELISA Kits
-
Protein Electrophoresis and Blotting
-
Protein and Antibody Purification
-
Recombinant Proteins
-
Molecular Biology
-
Stable Cell Lines
-
Cell Isolation and Activation
-
IVD Raw Materials
-
Therapy Applications
-
Resources
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Anti-Camelid VHH]()
MonoRab™ Anti-VHH Antibodies
-
![ELISA Kits]()
ELISA Kits
-
![Precast Gels]()
SurePAGE™ Precast Gels
-
![Quatro ProAb Automated Protein and Antibody Purification System]()
AmMag™ Quatro ProAb Automated Protein and Antibody Purification System
-
![Target Proteins]()
Target Proteins
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Stable Cell Lines]()
Stable Cell Lines
-
![Cell Isolation and Activation]()
Cell Isolation and Activation
-
![Quick
Order]()
Quick Order
-
![Quick
Order]()
Quick Order
- APPLICATIONS
- RESOURCES
- ABOUT US
CYC7 cDNA ORF clone, Leishmania infantum JPCM5
-
Gene
-
Clones
gRNAs
The following CYC7 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the CYC7 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.
-
Reference Sequences (Refseq)
CloneID OLc04733 Clone ID Related Accession (Same CDS sequence) XM_001467186.1 Accession Version XM_001467186.1 Latest version! Documents for ORF clone product in default vector Sequence Information ORF Nucleotide Sequence (Length: 762bp)
Protein sequence
SNPVector pcDNA3.1-C-(k)DYK or customized vector 
User ManualClone information Clone Map MSDSTag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags ORF Insert Method CloneEZ™ Seamless cloning technology Insert Structure linear Update Date 1436889600000 Organism Leishmania infantum JPCM5 Product putative CYC2-like protein Comment Comment: PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. This record is derived from an annotated genomic sequence (NC_009414). COMPLETENESS: incomplete on both ends.
1
61
121
181
241
301
361
421
481
541
601
661
721ATGCCTTTGC GAGCTTGTGT ATACAGGACG CCGGCGCAGG CCCGCTTGGT CGAGGTTGTC
TCCGGTTATG TCCAGCATCT TATGGATGTG CAGGCATCTA GGTGCACTGA GACCGCCCTT
GACGGGCATG TGGTCCCCCC GCCGAACGCA AAGTACCCTT CCCACGACTT CTTTTGTGCG
ACTCACGCGC CTGCGATCTC GGTGAAGAGG TACACGGAGC GCCTAGTGAC GTACATGCAC
TGCTCGCCCG AAGCATTTGT GTTTGCCGTC GCCTACCTGC GGCGGCTGGT GCTAAGCGGA
TTCCCGGTGC ATATGCGGTC TATCCATCGT CTGCTGTTAA CAGCCGTCTT GGTGGCCCTC
AAGTGTAGAG ACGACGTGTA CTACCACATG AGCTTCTACG CTGAGGTTGG TGGCGTTACC
TCGAAGGACT TGCGCATAAT GGAGATTCGG TTTCTCTCCG ACCTTATCCG CTTCGAAGGC
GAGGTATCTC TAGCAGATTA CCATGTCGTC ATGGTGGACA TCATGCGCGT GACGGAACGG
CGCATGATAA CGAATATTAA CGGCAAGACG GAGTTGTGCA ACCGATGCGG CATGTCTGCA
GGCGCCTTCA CCACCTCGAC CCCAGGAGAT CTTGGCTGCC TACACTGCAA GGGTGACGCG
TTCGCACAAT CGTGGACTAG CGAGTGCGAA CTGTTTTGGG GGCCGCTAAA TTCTGCTTTC
TCACTTCCCG CCGGAGAGGT CCGAAAGACA CTTTCATGCT AAThe stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
RefSeq XP_001467223.1 CDS 1..762 Translation 
Target ORF information:
RefSeq Version XM_001467186.1 Organism Leishmania infantum JPCM5 Definition Leishmania infantum JPCM5 putative CYC2-like protein (CYC7), partial mRNA. Target ORF information:
Epitope DYKDDDDK Bacterial selection AMPR Mammalian selection NeoR Vector pcDNA3.1+/C-(K)DYK 
XM_001467186.1
ORF Insert Sequence:
1
61
121
181
241
301
361
421
481
541
601
661
721ATGCCTTTGC GAGCTTGTGT ATACAGGACG CCGGCGCAGG CCCGCTTGGT CGAGGTTGTC
TCCGGTTATG TCCAGCATCT TATGGATGTG CAGGCATCTA GGTGCACTGA GACCGCCCTT
GACGGGCATG TGGTCCCCCC GCCGAACGCA AAGTACCCTT CCCACGACTT CTTTTGTGCG
ACTCACGCGC CTGCGATCTC GGTGAAGAGG TACACGGAGC GCCTAGTGAC GTACATGCAC
TGCTCGCCCG AAGCATTTGT GTTTGCCGTC GCCTACCTGC GGCGGCTGGT GCTAAGCGGA
TTCCCGGTGC ATATGCGGTC TATCCATCGT CTGCTGTTAA CAGCCGTCTT GGTGGCCCTC
AAGTGTAGAG ACGACGTGTA CTACCACATG AGCTTCTACG CTGAGGTTGG TGGCGTTACC
TCGAAGGACT TGCGCATAAT GGAGATTCGG TTTCTCTCCG ACCTTATCCG CTTCGAAGGC
GAGGTATCTC TAGCAGATTA CCATGTCGTC ATGGTGGACA TCATGCGCGT GACGGAACGG
CGCATGATAA CGAATATTAA CGGCAAGACG GAGTTGTGCA ACCGATGCGG CATGTCTGCA
GGCGCCTTCA CCACCTCGAC CCCAGGAGAT CTTGGCTGCC TACACTGCAA GGGTGACGCG
TTCGCACAAT CGTGGACTAG CGAGTGCGAA CTGTTTTGGG GGCCGCTAAA TTCTGCTTTC
TCACTTCCCG CCGGAGAGGT CCGAAAGACA CTTTCATGCT AAThe stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
-
PubMed
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania.
Genome research21(12)2129-42(2011 Dec)
Rogers MB,Hilley JD,Dickens NJ,Wilkes J,Bates PA,Depledge DP,Harris D,Her Y,Herzyk P,Imamura H,Otto TD,Sanders M,Seeger K,Dujardin JC,Berriman M,Smith DF,Hertz-Fowler C,Mottram JC
Comparative genomic analysis of three Leishmania species that cause diverse human disease.
Nature genetics39(7)839-47(2007 Jul)
Peacock CS,Seeger K,Harris D,Murphy L,Ruiz JC,Quail MA,Peters N,Adlem E,Tivey A,Aslett M,Kerhornou A,Ivens A,Fraser A,Rajandream MA,Carver T,Norbertczak H,Chillingworth T,Hance Z,Jagels K,Moule S,Ormond D,Rutter S,Squares R,Whitehead S,Rabbinowitsch E,Arrowsmith C,White B,Thurston S,Bringaud F,Baldauf SL,Faulconbridge A,Jeffares D,Depledge DP,Oyola SO,Hilley JD,Brito LO,Tosi LR,Barrell B,Cruz AK,Mottram JC,Smith DF,Berriman M
-
-
Most Popular Services
-
Services & Products
-
News & Blogs
- Transforming OMVs into a Modular Vaccine Platform | GenScript
- Thousands of novel protein families identified in the human body
- Cerebral Organoids Provide a Platform to Screen Alzheimer’s Drugs
- Structural Properties of Pangolin-CoV Spike Glycoprotein Reveal Evolutionary Insight of SARS-CoV-2
- Cannabinoid agonist induces weight loss without adverse central nervous system effects
- CRISPR-based screening identifies key players in tumor mediated immune evasion
- Combinatorial vs Sequential Optimization for Metabolic Pathway Engineering, What Are The Advantages?
- Induced pluripotent stem cells - How they are produced and how we use them
-
-
-
PubMed
-
